Skip to content

Clinical trials

Completed Phase 3 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 3 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20052
20061
20071
20093
20102
20112
20142
20163
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Eli Lilly and Company2
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1
Celgene1
Genentech, Inc.1
Genzyme, a Sanofi Company1
Imunon1
Incheon St.Mary's Hospital1
Institut Paoli-Calmettes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma21
Carcinoma5
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Digestive System Diseases3
Digestive System Neoplasms3
Neoplasms by Site3
Pancreatic Neoplasms3
Stomach Neoplasms3
Carcinoma, Large Cell2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.